PancytopeniaBone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousAnemia, AplasticWhole-Body IrradiationBone and BonesSyndromeHematopoietic Stem Cell TransplantationTransplantation ConditioningLeukemiaBone Marrow DiseasesLiver TransplantationTransplantation ChimeraTissue DonorsGraft SurvivalBusulfanBone Marrow PurgingHematopoietic Stem CellsHistocompatibility TestingBone Marrow ExaminationHistocompatibilityCyclophosphamideTransplantation, IsogeneicHematopoiesisMyelodysplastic SyndromesKidney TransplantationRecurrenceTreatment OutcomeImmunosuppressive AgentsMice, Inbred C57BLLeukemia, Myeloid, AcuteCombined Modality TherapyRemission InductionRadiation ChimeraLeukemia, Myelogenous, Chronic, BCR-ABL PositiveTime FactorsHematologic NeoplasmsGraft RejectionHepatic Veno-Occlusive DiseasePrecursor Cell Lymphoblastic Leukemia-LymphomaAcute DiseaseBone RemodelingFatal OutcomeBone Marrow NeoplasmsTransplantation ImmunologyLeukemia, MyeloidGraft vs Host ReactionColony-Forming Units AssayHematologic DiseasesHistiocytosis, Non-Langerhans-CellImmunosuppressionLymphocyte DepletionStem Cell TransplantationRetrospective StudiesLymphoma, Non-HodgkinLeukocyte TransfusionHeart TransplantationSevere Combined ImmunodeficiencyT-LymphocytesChimeraSurvival AnalysisHLA AntigensLung TransplantationLymphohistiocytosis, HemophagocyticAntineoplastic Combined Chemotherapy ProtocolsCyclosporineLeukocyte CountBone DensityActuarial AnalysisLymphocyte TransfusionGranulocyte Colony-Stimulating FactorBlood Cell CountNuclear FamilySpleenFollow-Up StudiesCarmustineOrgan TransplantationCell DifferentiationHypersplenismGraft vs Tumor EffectSurvival RateCytarabineGraft vs Leukemia EffectCytomegalovirus InfectionsBone ResorptionPrognosisMelphalanMice, Inbred BALB CDisease-Free SurvivalFanconi AnemiaFlow CytometryEtoposideLymphomaMultiple MyelomaCells, CulturedThrombocytopenia